These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32296426)

  • 1. Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors.
    Dolcetti R; López-Soto A; Dal Col J
    Front Immunol; 2020; 11():507. PubMed ID: 32296426
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Castiello L; Aricò E; D'Agostino G; Santodonato L; Belardelli F
    Front Immunol; 2019; 10():2303. PubMed ID: 31611878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells in tumor immunology and immunotherapy.
    Turtle CJ; Hart DN
    Curr Drug Targets; 2004 Jan; 5(1):17-39. PubMed ID: 14738216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers.
    Nigro A; Montico B; Casolaro V; Dal Col J
    Methods Mol Biol; 2019; 1884():317-333. PubMed ID: 30465213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy using dendritic cells picks up steam.
    McCann J
    J Natl Cancer Inst; 1997 Apr; 89(8):541-2. PubMed ID: 9106639
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of Immune Checkpoint Inhibitor Combined with Dendritic Cell Therapy and Hyperthermia].
    Takeda T; Kubota Y; Takeda T; Tanaka C; Morita S; Hattori N; Takeda H; Yokoyama Y; Yamamoto H
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1472-1474. PubMed ID: 30382049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-dendritic cell fusion technology and immunotherapy strategies.
    Shu S; Cohen P
    J Immunother; 2001; 24(2):99-100. PubMed ID: 11265778
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy and Vaccine Development.
    Leung C; Münz C; Riemer A
    J Immunol Res; 2018; 2018():8751027. PubMed ID: 30009188
    [No Abstract]   [Full Text] [Related]  

  • 9. Dendritic cell vaccination and other strategies to tip the balance of the immune system : DC2007 5th International Meeting, July 16-18, Bamberg, Germany.
    Schaft N; Birkholz K; Hofmann C; Schmid M; Theiner G; Dörrie J
    Cancer Immunol Immunother; 2008 Jun; 57(6):913-28. PubMed ID: 18236041
    [No Abstract]   [Full Text] [Related]  

  • 10. The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy.
    Cannon MJ; Block MS; Morehead LC; Knutson KL
    Immunotherapy; 2019 Feb; 11(2):75-79. PubMed ID: 30730268
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy.
    Seya T; Takeda Y; Takashima K; Yoshida S; Azuma M; Matsumoto M
    Proc Jpn Acad Ser B Phys Biol Sci; 2018; 94(3):153-160. PubMed ID: 29526974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy exploiting the versatility of dendritic cells.
    Kadowaki N
    Ther Apher Dial; 2003 Jun; 7(3):312-7. PubMed ID: 12924606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell vaccine and cancer treatment: new patents.
    Aleixo AA; Michelin MA; Murta EF
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):26-9. PubMed ID: 24397783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hybrid cell vaccination approach to cancer immunotherapy.
    Trefzer U; Herberth G; Sterry W; Walden P
    Ernst Schering Res Found Workshop; 2000; (30):154-66. PubMed ID: 10943322
    [No Abstract]   [Full Text] [Related]  

  • 15. Monocyte-derived dendritic cells: a promising armament for immunotherapy in human malignancies.
    Yi Q; Kwak LW
    Clin Cancer Res; 2005 Feb; 11(3):966-7. PubMed ID: 15709160
    [No Abstract]   [Full Text] [Related]  

  • 16. Active immunization against cancer with dendritic cells: the near future.
    Steinman RM; Dhodapkar M
    Int J Cancer; 2001 Nov; 94(4):459-73. PubMed ID: 11745430
    [No Abstract]   [Full Text] [Related]  

  • 17. Dendritic cell-based vaccines and therapies for cancer.
    Tatsumi T; Storkus WJ
    Expert Opin Biol Ther; 2002 Dec; 2(8):919-28. PubMed ID: 12517270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Dendritic Cells by Nanotechnology-Based Immunotherapeutic Strategies.
    Mogrão J; da Costa CA; Gaspar R; Florindo HF
    J Biomed Nanotechnol; 2016 Mar; 12(3):405-34. PubMed ID: 27280242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic role of dendritic cells in cancer immunotherapy.
    Lemoli RM; Curti A; Fogli M; Ferri E; Baccarani M
    Haematologica; 2002 Aug; 87(8 Suppl):62-6. PubMed ID: 12412393
    [No Abstract]   [Full Text] [Related]  

  • 20. In situ vaccination with biocompatibility controllable immuno-sensitizer inducing antitumor immunity.
    Shin H; Na K
    Biomaterials; 2019 Mar; 197():32-40. PubMed ID: 30639548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.